ZA200108238B - Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines. - Google Patents

Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines.

Info

Publication number
ZA200108238B
ZA200108238B ZA200108238A ZA200108238A ZA200108238B ZA 200108238 B ZA200108238 B ZA 200108238B ZA 200108238 A ZA200108238 A ZA 200108238A ZA 200108238 A ZA200108238 A ZA 200108238A ZA 200108238 B ZA200108238 B ZA 200108238B
Authority
ZA
South Africa
Prior art keywords
endoparasiticidal
piperazines
depsipeptides
cyclic depsipeptides
containing cyclic
Prior art date
Application number
ZA200108238A
Other languages
English (en)
Inventor
Achim Harder
Georg Samson-Himmelstjerna
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7907825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200108238(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA200108238B publication Critical patent/ZA200108238B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA200108238A 1999-05-12 2001-10-08 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines. ZA200108238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19921887A DE19921887A1 (de) 1999-05-12 1999-05-12 Endoparasitizide Mittel

Publications (1)

Publication Number Publication Date
ZA200108238B true ZA200108238B (en) 2002-12-24

Family

ID=7907825

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108238A ZA200108238B (en) 1999-05-12 2001-10-08 Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines.

Country Status (26)

Country Link
EP (1) EP1189615B1 (xx)
JP (1) JP2002544224A (xx)
KR (1) KR100704717B1 (xx)
CN (1) CN1224391C (xx)
AT (1) ATE258795T1 (xx)
AU (1) AU768910B2 (xx)
BR (1) BR0010499A (xx)
CA (1) CA2373827C (xx)
CZ (1) CZ300782B6 (xx)
DE (2) DE19921887A1 (xx)
DK (1) DK1189615T3 (xx)
ES (1) ES2211558T3 (xx)
HK (1) HK1047228B (xx)
HR (1) HRP20010918B1 (xx)
HU (1) HUP0201201A3 (xx)
MX (1) MXPA01011455A (xx)
NO (1) NO328870B1 (xx)
PL (1) PL200951B1 (xx)
PT (1) PT1189615E (xx)
RS (1) RS50169B (xx)
RU (1) RU2250779C2 (xx)
SK (1) SK285494B6 (xx)
TR (2) TR200103240T2 (xx)
UA (1) UA72520C2 (xx)
WO (1) WO2000069425A2 (xx)
ZA (1) ZA200108238B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
KR101671325B1 (ko) * 2015-01-09 2016-11-02 한국생명공학연구원 신규한 고리형 뎁시펩타이드계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 항균용 약학적 조성물
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
RU2020107484A (ru) 2015-12-28 2020-03-19 Мериал, Инк. Противогельминтные депсипептидные соединения
WO2018093920A1 (en) 2016-11-16 2018-05-24 Merial, Inc. Anthelmintic depsipeptide compounds
US20230339874A1 (en) * 2020-09-11 2023-10-26 The Governing Council Of The University Of Toronto Piperazinyl compounds and methods for treating nematode infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
JPS6471865A (en) * 1987-09-11 1989-03-16 Nichibai Boeki Kk 1-alkylcarbamoyl-4-methylpiperazine derivative
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
ES2170101T3 (es) * 1993-09-06 2002-08-01 Fujisawa Pharmaceutical Co Compuesto ciclodepsipeptido.
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
AU6860296A (en) * 1995-09-07 1997-03-27 Pharmacia & Upjohn Company Cycloanthelmintic inhibitors
WO1998037088A1 (en) * 1997-02-19 1998-08-27 Meiji Seika Kaisha Ltd. Derivatives of cyclodepsipeptide, pf1022 substance
US6355615B1 (en) * 1997-06-04 2002-03-12 Bayer Aktiengesellschaft Desoxycyclodepsipeptides and their use for combatting endoparasites
WO2000008047A1 (fr) * 1998-08-04 2000-02-17 Nisshin Flour Milling Co., Ltd. Derives de depsipeptides comportant des noyaux de piperazinone

Also Published As

Publication number Publication date
TR200103240T2 (tr) 2002-04-22
PL200951B1 (pl) 2009-02-27
EP1189615A2 (de) 2002-03-27
JP2002544224A (ja) 2002-12-24
CZ20014060A3 (cs) 2002-06-12
HUP0201201A3 (en) 2003-03-28
BR0010499A (pt) 2002-02-13
WO2000069425A3 (de) 2001-03-15
YU80501A (sh) 2004-09-03
WO2000069425A2 (de) 2000-11-23
DE19921887A1 (de) 2000-11-16
KR20010109527A (ko) 2001-12-10
ATE258795T1 (de) 2004-02-15
HK1047228B (zh) 2006-07-21
HK1047228A1 (en) 2003-02-14
CA2373827A1 (en) 2000-11-23
HUP0201201A2 (en) 2002-08-28
NO20015398L (no) 2001-11-05
EP1189615B1 (de) 2004-02-04
HRP20010918B1 (en) 2011-01-31
SK16262001A3 (sk) 2002-03-05
CA2373827C (en) 2008-09-16
AU5523700A (en) 2000-12-05
PL351376A1 (en) 2003-04-07
DK1189615T3 (da) 2004-06-07
RS50169B (sr) 2009-05-06
DE50005213D1 (de) 2004-03-11
ES2211558T3 (es) 2004-07-16
KR100704717B1 (ko) 2007-04-09
MXPA01011455A (es) 2002-07-30
PT1189615E (pt) 2004-05-31
HRP20010918A2 (en) 2003-04-30
NO20015398D0 (no) 2001-11-05
CN1352559A (zh) 2002-06-05
AU768910B2 (en) 2004-01-08
CN1224391C (zh) 2005-10-26
RU2250779C2 (ru) 2005-04-27
SK285494B6 (sk) 2007-02-01
NO328870B1 (no) 2010-06-07
UA72520C2 (uk) 2005-03-15
TR200401875T2 (tr) 2005-01-24
CZ300782B6 (cs) 2009-08-12

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
IL140710A0 (en) Pulmonary delivery of active agents
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
IL140930A0 (en) Compounds and compositions for delivering active agents
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
BG64475B1 (bg) Ципразидонови соли
DE60024414D1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
IL153297A0 (en) Compounds and compositions for delivering active agents
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR0014381A (pt) Derivados de 5-beta-sapogenina e pseudossapogenina e seu uso no tratamento de demência
YU13301A (sh) Muskarinski agonisti i antagonisti
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE69803773T2 (de) Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion
PL351376A1 (en) Endoparasiticidal synergistic combination containing cyclic depsipeptides and piperazines
MXPA02012015A (es) Ligandos de receptores para integrinas.
DK1061938T3 (da) Orale sammensætninger med cytotoksiske proteiner i lav dosis
ATE251619T1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one
UA37545A (uk) Калієва сіль n-(1,4-діоксо-3-метил-1,4-дигідронафт-2-іл) гліцину, що проявляє антигіпоксичну та протиішемічну дію